|
|
| | (−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) Basic information |
| | (−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) Chemical Properties |
| | (−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) Usage And Synthesis |
| Description | (−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) (Item No. 40976) is intended for use as an internal standard for the quantification of (−)-11-hydroxy-Δ8-THC (Item No. 29469) by GC- or LC-MS. (−)-11-hydroxy-Δ8-THC is categorized as a phytocannabinoid metabolite.1,2 (–)-11-hydroxy-Δ8-THC is a metabolite of Δ8-THC (Item Nos. ISO60158 | 14042). It has analgesic activity in mice. (–)-11-hydroxy-Δ8-THC-d3 is regulated as a Schedule I compound in the United States. (−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) (Item No. 40976) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.WARNING This product is not for human or veterinary use. |
| | (−)-11-hydroxy-Δ8-THC-d3 (exempt preparation) Preparation Products And Raw materials |
|
|
Tag:(−)-11-hydroxy-Δ8-THC-d3 (exempt preparation)
Related Product Information
|
|
(6aR,8S,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1,8-diol
8-hydroxy-delta(9)-tetrahydrocannabinol
6H-Dibenzo[b,d]pyran-9-carboxylic acid, 6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-3-(pentyl-5,5,5-d3)-, (6aR,10aR)-
(−)-11-hydroxy-Δ8-THC-d3
(−)-11-nor-9-carboxy-Δ8-THC-d9 (CRM)
|